Shareholding disclosure

Molecular Partners AG

Collectively declared rate

8.63%

Threshold

Crossed upwards

Timeline

Published

11.08.2015

Transaction

04.08.2015

Voting rights breakdown

Voting rights acquired8.63%
Voting rights sold0%
Below threshold0%

Declared beneficial owners · 2

A single, collectively filed disclosure: the voting-rights rate applies to the whole group, not to each person.

Notice details

CategoryGroup of shareholders
ExchangeXSWX

Notification ID

TBF8A00017

Beneficial owner

Johnson & Johnson

Declared address

Johnson & Johnson, New Brunswick, New Jersey 08933

End of lock-up period on August 4, 2015 pursuant to the underwriting agreement dated October 7, 2014, between Molecular Partners Ltd., J.P. Morgan Securities plc (as global coordinator), UBS AG (as joint lead manager and together with J.P. Morgan Securities, the "Joint Bookrunners"), Cowen and Company, LLC (as co-manager) and Bank am Bellevue AG (as co-manager). 100% of the shares/voting rights in Johnson & Johnson Innovation-JJDC, Inc. (formerly known as Johnson & Johnson Development Corporation) are held by Johnson & Johnson.

These figures aggregate public disclosures. They are not investment advice.

Source: SIX Exchange Regulation

insider24.ch

Never miss a market signal again

Pro alertsEmail and Telegram after publication
Unlimited company trackingUnlimited watchlist with the Pro plan
Monday recapYour stocks' essentials at the open